REFERENCES
1. Korrel M, Jones LR, van Hilst J, et al.; European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS). Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Lancet Reg Health Eur. 2023;31:100673.
2. Gagner M, Pomp A. Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc. 1994;8:408-10.
3. Palanivelu C, Senthilnathan P, Sabnis SC, et al. Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours. Br J Surg. 2017;104:1443-50.
4. van Hilst J, de Rooij T, Bosscha K, et al.; Dutch Pancreatic Cancer Group. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial. Lancet Gastroenterol Hepatol. 2019;4:199-207.
5. Poves I, Burdío F, Morató O, et al. Comparison of perioperative outcomes between laparoscopic and open approach for pancreatoduodenectomy: the PADULAP randomized controlled trial. Ann Surg. 2018;268:731-9.
6. de Graaf N, Emmen AMLH, Ramera M, et al.; European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS). Minimally invasive versus open pancreatoduodenectomy for pancreatic and peri-ampullary neoplasm (DIPLOMA-2): study protocol for an international multicenter patient-blinded randomized controlled trial. Trials. 2023;24:665.
7. de Graaf N, Emmen A, Ramera M, et al. Minimally invasive versus open pancreatoduodenectomy for resectable neoplasm (diploma-2). HPB. 2025;27:S1-2.
8. Klotz R, Mihaljevic AL, Kulu Y, et al. Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trial. Lancet Reg Health Eur. 2024;39:100864.
9. Liu Q, Li M, Gao Y, et al. Effect of robotic versus open pancreaticoduodenectomy on postoperative length of hospital stay and complications for pancreatic head or periampullary tumours: a multicentre, open-label randomised controlled trial. Lancet Gastroenterol Hepatol. 2024;9:428-37.
10. Jin J, Shi Y, Chen M, et al. Robotic versus open pancreatoduodenectomy for pancreatic and periampullary tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial. Trials. 2021;22:954.
11. Jones LR, Zwart MJW, de Graaf N, et al.; International Consortium on Minimally Invasive Pancreatic Surgery (I-MIPS). Learning curve stratified outcomes after robotic pancreatoduodenectomy: international multicenter experience. Surgery. 2024;176:1721-9.
12. Wakabayashi T, Gaudenzi F, Nie Y, et al. Reduced pancreatic fistula rates and comprehensive cost analysis of robotic versus open pancreaticoduodenectomy. Surg Endosc. 2025;39:3921-9.
13. Li R, Zhang X, Chen W, et al. Robotic pancreatoduodenectomy reduces grade B pancreatic fistula in patients with a small main pancreatic duct: a propensity score-matched study compared to laparoscopic pancreatoduodenectomy. Ann Med. 2025;57:2527357.
14. Fuji T, Takagi K, Umeda Y, et al. Impact of robotic surgery on postoperative pancreatic fistula for high-risk pancreaticojejunostomy after pancreatoduodenectomy. Dig Surg. 2025;42:49-58.
15. Kim HE, Jung HS, Han Y, et al. Evaluation of feasibility and clinical outcomes of robot-assisted pancreaticoduodenectomy after neoadjuvant treatment for patients with advanced pancreatic ductal adenocarcinoma: a retrospective propensity score-matched cohort study. Ann Surg Treat Res. 2025;109:61-70.
